233 related articles for article (PubMed ID: 31494973)
1. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
Wang YJ; Lin ET; Chen YT; Chiu PC; Lin BS; Chiang HM; Huang YH; Wang KY; Lin HY; Chang TM; Chang CC
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):624-632. PubMed ID: 31494973
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System.
Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM
Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549
[No Abstract] [Full Text] [Related]
3. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
4. Photoaging Reversibility in Asian Patients With Melasma Treated Using Picosecond Lasers With a Diffractive Lens Array: A 1-Year Prospective Observational Cohort Study.
Lin ET; Chiang HM; Lin BS; Huang YH; Chang CC
Dermatol Surg; 2021 Jan; 47(1):e10-e14. PubMed ID: 32271179
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
Chan R; Park KC; Lee MH; Lee ES; Chang SE; Leow YH; Tay YK; Legarda-Montinola F; Tsai RY; Tsai TH; Shek S; Kerrouche N; Thomas G; Verallo-Rowell V
Br J Dermatol; 2008 Sep; 159(3):697-703. PubMed ID: 18616780
[TBL] [Abstract][Full Text] [Related]
6. Topical metformin in the treatment of melasma: A preliminary clinical trial.
Banavase Channakeshavaiah R; Andanooru Chandrappa NK
J Cosmet Dermatol; 2020 May; 19(5):1161-1164. PubMed ID: 31502392
[TBL] [Abstract][Full Text] [Related]
7. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
[TBL] [Abstract][Full Text] [Related]
8. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
[TBL] [Abstract][Full Text] [Related]
9. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
Grimes PE
Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
11. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
Draelos Z
Dermatol Surg; 2011 Jan; 37(1):126-7. PubMed ID: 21214668
[No Abstract] [Full Text] [Related]
12. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
[TBL] [Abstract][Full Text] [Related]
13. A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians.
Manuskiatti W; Yan C; Tantrapornpong P; Cembrano KAG; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2021 Jan; 53(1):95-103. PubMed ID: 32865858
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial.
Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L
Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
Gong Z; Lai W; Zhao G; Wang X; Zheng M; Li L; Yang Q; Dang Y; Liu L; Zou Y
Clin Drug Investig; 2015 Jun; 35(6):385-95. PubMed ID: 25989732
[TBL] [Abstract][Full Text] [Related]
16. The role of 755-nm alexandrite picosecond laser in melasma management.
Pulumati A; Jaalouk D; Algarin YA; Nouri K
Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Split-Face Study of the Picosecond Alexandrite Laser With Specialized Lens Array for Facial Photoaging in Chinese.
Ge Y; Guo L; Wu Q; Zhang M; Zeng R; Lin T
J Drugs Dermatol; 2016 Nov; 15(11):1390-1396. PubMed ID: 28095552
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
20. Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P; Kelly AP; Torok H; Willis I
Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
